| Property | Value |
|---|
|
?:abstract
|
-
Severe acute respiratory disorder corona virus 2 (SARS-CoV-2) is a recently developing human irresistible corona virus that causes COVID-19, which has been perceived as a pandemic by the World Health Organization (WHO) on March eleventh It is a significant wellspring of fiasco in 21st century There is still no immunization, no complete treatment for this infection since its pathogenesis and multiplication pathways are as yet obscure The endeavors of universal wellbeing specialists have since concentrated on Rapid determination and disengagement of patients just as the quest for treatments ready to counter the most genuine impacts of the illness This sickness or infection presents an unpredicted test to recognize powerful medication for anticipation and treatment In any case, the absence of explicit medications to forestall or treat an attack is a significant need at this present purpose of time In such manner, we led an efficient audit to recognize major druggable target in coronavirus
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
International_Journal_of_Pharmaceutical_Sciences_Review_and_Research
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Recent updates on anti-viral drug design against covid – 19 using suitable enzyme targets
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}